Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important

被引：1
|
作者：
Markopoulos, Christos [1 ]
机构：
[1] Univ Athens, Dept Surg, Sch Med, Athens 11521, Greece
来源：
BREAST CANCER RESEARCH | 2010年 / 12卷 / 04期
关键词：
PREVENTION;
D O I：
10.1186/bcr2609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [22] Clinical characteristics of bone fractures in breast cancer women receiving adjuvant aromatase inhibitors
    Wojtacki, J.
    Wiraszka, R.
    Markowicz, A.
    Piotrowska, M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 200 - 201
  • [23] Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer
    Nogues, Xavier
    Servitja, Sonia
    Jesus Pena, Maria
    Prieto-Alhambra, Daniel
    Nadal, Rosa
    Mellibovsky, Leonardo
    Albanell, Joan
    Diez-Perez, Adolfo
    Tusquets, Ignasi
    MATURITAS, 2010, 66 (03) : 291 - 297
  • [24] Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer
    Villa, Paola
    Lassandro, Anna P.
    Amar, Inbal D.
    Vacca, Lorenzo
    Moruzzi, Maria C.
    Ferrandina, Gabriella
    Terribile, Daniela
    Masetti, Riccardo
    Scambia, Giovanni
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (01): : 33 - 39
  • [25] Postmenopausal breast cancer, aromatase inhibitors, and bone health
    Heneghan, H. M.
    McKenna, M.
    Walshe, J.
    Rothwell, J.
    Evoy, D.
    Geraghty, J.
    McDermott, E.
    Prichard, R. S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 416 - 417
  • [26] Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy
    Bone, H. G.
    Ellis, G.
    Yuen, C. K.
    Kendler, D. L.
    Fan, M.
    Wang, H.
    Kim, D.
    Liu, Y.
    Dansey, R.
    Martin, J. San
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S38 - S38
  • [27] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN CAUCASIAN WOMEN WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Khachidze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S228 - S229
  • [28] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
  • [29] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Kwan, Marilyn L.
    Yao, Song
    Laurent, Cecile A.
    Roh, Janise M.
    Quesenberry, Charles P., Jr.
    Kushi, Lawrence H.
    Lo, Joan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 523 - 530
  • [30] Bone mineral density in women with breast cancer
    Kocaaga, Z.
    Turan, Y.
    Duransoy, A.
    Gurgan, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S27 - S27
12345